May 7, 2021
Talaris Therapeutics Announces Pricing of Initial Public Offering
BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing…
Pharmaceuticals, Biotechnology and Life Sciences
Author: GlobeNewswire
May 7, 2021
Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
FLORHAM PARK, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused…
May 7, 2021
UPDATE – Efferent Labs Expands Development Collaboration with Gore
CHARLESTON, S.C., May 06, 2021 (GLOBE NEWSWIRE) — Today, Efferent Labs announces an expanded development collaboration with W. L. Gore…
May 7, 2021
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting
CANTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on…
May 7, 2021
Eloxx Pharmaceuticals Reports First Quarter 2021 Financial and Operating Results and Provides Business Update
Acquisition of Zikani Therapeutics, Ribosomal Modulation Company; Combined Company Advancing Ribosomal RNA-Targeted Genetic Therapies Additional Treatment Arm Added to Ongoing…
May 7, 2021
NextCure Reports First Quarter 2021 Financial Results
BELTSVILLE, Md., May 06, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and…
May 7, 2021
CORRECTING and REPLACING — Tricida Announces First Quarter 2021 Financial Results
Webcast Today at 4:30 pm Eastern TimeSOUTH SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE) — In a release issued under…
May 7, 2021
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients…
May 7, 2021
Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance
PRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its…
May 7, 2021
Nephros Announces Results for Quarter Ended March 31, 2021
Net Revenue of $2.7 Million; Highest First Quarter in Company History SOUTH ORANGE, NJ, May 06, 2021 (GLOBE NEWSWIRE) —…